Physiologic Change of Posterior Ocular Segment During Pregnancy
NCT ID: NCT04731415
Last Updated: 2021-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
69 participants
INTERVENTIONAL
2021-07-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The physiologic ocular changes during pregnancy are mainly the result of hormonal and blood volume increase, and then are usually marked in the third trimester.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiologic Changes of Posterior Ocular Segment During the Menstrual Cycle
NCT04731207
Comparison of Posterior Ocular Changes Between Singleton Pregnancy and Multifetal Pregnancy.
NCT04773561
Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor
NCT03679156
Retinal and Choroidal Microvascular Changes During Pregnancy Period Detected With Optical Coherence Tomography Angiography
NCT04950855
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
NCT05650047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Melanogenesis of eyelid and facial skin -\> melasma
* Cellular alteration of lacrimal and meibomian gland -\> dry eye symptoms
* Increased corneal thickness and corneal curvature -\> contact lens intolerance
* Increased lens thickness -\> loss of accommodation
* Decreased intraocular pressure -\> better glaucoma control There are few studies of posterior changes in pregnant women. Many limitations of previous publications includes lack of internal control and no data of postpartum contraception. However, choroidal thickness seems to be thicker in pregnant women than non-pregnant women. The other changes are non-inclusive.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy pregnant women
Optical coherence tomography and Optical coherence tomography angiography using Optovue® were performed in each trimester and at 6 weeks after childbirth.
Optical coherence tomography and optical coherence tomography angiography (Optovue®)
Optical coherence tomography and optical coherence tomography angiography (Optovue®) were performed in each trimesters and at 6 weeks after childbirth.
1. st trimester : gestational age 8-12 weeks
2. nd trimester : gestational age 24-28 weeks
3. rd trimester : gestational age 34-38 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical coherence tomography and optical coherence tomography angiography (Optovue®)
Optical coherence tomography and optical coherence tomography angiography (Optovue®) were performed in each trimesters and at 6 weeks after childbirth.
1. st trimester : gestational age 8-12 weeks
2. nd trimester : gestational age 24-28 weeks
3. rd trimester : gestational age 34-38 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Gestational age \< 12 weeks
* Written informed consent
Exclusion Criteria
* History of vitreoretinal diseases such as retinal vasculitis
* History of intraocular laser treatments or intraocular surgeries
* History of systemic diseases such as diabetes mellitus and thyroid disease
* Refractive error; spherical equivalence \> 4 diopters
* Clear ocular media
* Could not be taken the images by non-dilated pupil
Withdrawal Criteria:
* Preterm labor; gestational age \< 34 weeks
* Multifetal pregnancy was demonstrated by ultrasound
* Severe labor and delivery complications such as
* Severe postpartum complications such as postpartum bleeding
* Taking hormone during the follow-up period
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Suthasinee Sinawat
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suthasinee Sinawat, MD
Role: PRINCIPAL_INVESTIGATOR
KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Khon Kaen University
Khon Kaen, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE631577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.